Bioiberica will present B-2Cool, a natural ingredient supplying native (undenatured) type II collagen, whose efficacy has been confirmed in both animal models and clinical trials. Thanks to preserving the native form of the collagen molecule, when orally taken, B-2Cool works through an immune-mediated mechanism of action called Oral Tolerance that modulates the immune response against endogenous type II collagen. This helps reduce cartilage degradation and joint inflammation, thus improving joint pain and function. Bioiberica is a biotechnology company based in Barcelona (Spain) with more than 20 years expertise in the field of joint health. For more information visit our profile.